3-Methyloxazolidine, 95%, 250mg

4-BROMO-1-FLUORO-2-ISOCYANATOBENZENE, 95.0%, 1g

N-(((9H-Fluoren-9-yl)methoxy)carbonyl)-N-benzyl-L-alanine, 98%, 1g

2,1,3-Benzothiadiazole-5-carbaldehyde, 95.0%, 5g

(1r,4r)-4-Methylcyclohexanol, 97%, 25g

trans-Ethyl 4-aminocyclohexanecarboxylate, 95.0%, 250mg

7-Bromo-6-chloro-3,4-dihydro-2H-benzo[b][1,4]oxazine, 97%, 250mg

(1-ETHENYL-2-OXABICYCLO[2.2.2]OCTAN-4-YL)METHANOL, 95.0%, 250mg

2-Bromo-N-methylpyridin-4-amine, 95.0%, 2.5g

tert-Butyl ((S)-1-amino-1-oxo-3-((S)-2-oxopyrrolidin-3-yl)propan-2-yl)carbamate, 100mg

Ethyl 3-(4-methoxyphenyl)-3-oxopropanoate, 95.0%, 5g

1-(3,4-dimethylphenyl)-5-phenyl-4,5-dihydro-1H-pyrazole-3-carboxylic acid, 95.0%, 5g

Recipiente de reacción con brida plana, cilíndrico, graduado, con camisa de templado y vacío y válvula de drenaje, DN 100, 2000 ml, 250 mm, 1 pieza